您的购物车当前为空
EGFRT790M/L858R-IN-8(compound 9)靶向突变型EGFRT790M/L858R的IC50值为56.8 μM,表明其是EGFR的一种有效抑制剂。然而,该化合物对包括A549、A431、NHI-H1975在内的癌细胞系的抗增殖效果并不显著。

EGFRT790M/L858R-IN-8(compound 9)靶向突变型EGFRT790M/L858R的IC50值为56.8 μM,表明其是EGFR的一种有效抑制剂。然而,该化合物对包括A549、A431、NHI-H1975在内的癌细胞系的抗增殖效果并不显著。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 2-4周 | |
| 50 mg | ¥ 13,800 | 2-4周 | |
| 100 mg | ¥ 17,500 | 2-4周 |
EGFR T790M/L858R-IN-8 相关产品
| 产品描述 | EGFRT790M/L858R-IN-8 (compound 9) is a potent inhibitor of EGFR, specifically targeting the EGFRT790M/L858R mutations with an IC50 of 56.8 μM. This compound does not show significant antiproliferative effects on cancer cell lines A549, A431, and NHI-H1975. |
| 分子量 | 359.17 |
| 分子式 | C16H11BrN2O3 |
| CAS No. | 333419-97-9 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容